SUNNYVALE, Calif., Aug. 22 /PRNewswire-FirstCall/ -- Cepheid (Nasdaq: CPHD) today announced that its executives will be speaking at the following investor conferences, and invited investors to participate via webcast.

          Thomas Weisel Partners Healthcare Conference, Boston, MA
          Wednesday, September 3, 2008 at 2.05 p.m. Eastern Time
          R.W. Baird Small Cap Healthcare Conference, New York, NY
          Wednesday, September 10, 2008 at 9.00 a.m. Eastern Time
          UBS Global Life Sciences Conference, New York, NY
          Tuesday, September 23, 2008 at 9.00 a.m. Eastern Time

Accessing Webcasts

To access the live webcasts for these events, please visit Cepheid's website at http://www.cepheid.com/investors at least 15 minutes before the schedule start time to download any necessary audio or plug-in software. A replay of the webcast will be available shortly following the presentation and will remain available for at least 90 days.

About Cepheid

Cepheid (Nasdaq: CPHD), based in Sunnyvale, Calif., is an on-demand molecular diagnostics company that develops, manufactures, and markets fully-integrated systems and tests for genetic analysis in the clinical, industrial and biothreat markets. The Company's systems enable rapid, sophisticated genetic testing for organisms and genetic-based diseases by automating otherwise complex manual laboratory procedures. Cepheid's easy-to-use systems integrate a number of complicated and time-intensive steps, including sample preparation, DNA amplification and detection, which enable the analysis of complex biological samples in its proprietary test cartridges. Through its strong molecular biology capabilities, the Company is focusing on those applications where rapid molecular testing is particularly important, such as identifying infectious disease and cancer in the clinical market; food, agricultural, and environmental testing in the industrial market; and identifying bio-terrorism agents in the biothreat market.

     CONTACTS:
     For Media Inquiries:                    For Investor Inquiries:
     Jared Tipton                            Jacquie Ross
     Cepheid Corporate Communications        Cepheid Investor Relations
     Tel: (408) 400-8377                     Tel: (408) 400-8329
     jared.tipton@cepheid.com                jacquie.ross@cepheid.com

SOURCE Cepheid